In the present study, we have shown differences in the mRNA and protein expression profile for certain elements of the notch pathway (receptors, ligands, modulators and downstream signalling factors) between ovarian adenocarcinomas, borderline tumours and ovarian adenomas: We could show a higher HESl protein expression in ovarian cancers and borderline tumours in comparison to adenomas. This evidence concerns the gene HELT and adenoma.